- Report
- November 2023
- 630 Pages
Global
From €9067EUR$9,500USD£7,597GBP
- Report
- May 2023
- 160 Pages
Global
From €4723EUR$4,949USD£3,957GBP
The Lung Cancer Therapies market is composed of drugs used to treat lung cancer. These drugs are used to target the cancer cells, reduce the size of tumors, and reduce the spread of cancer. Commonly used drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is a type of drug therapy that uses drugs to kill cancer cells. Targeted therapy is a type of drug therapy that uses drugs to target specific molecules in cancer cells. Immunotherapy is a type of drug therapy that uses drugs to boost the body’s immune system to fight cancer. Hormone therapy is a type of drug therapy that uses drugs to block the hormones that help cancer cells grow.
Some companies in the Lung Cancer Therapies market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more